<DOC>
	<DOCNO>NCT01281748</DOCNO>
	<brief_summary>Clinical practice guideline management chronic obstructive pulmonary disease ( COPD ) recommend treatment systemic corticosteroid acute exacerbation . The result Cochrane systematic review show treatment systemic corticosteroid improve lung function first 72 hour exacerbation COPD effect outcome , particularly length hospital stay , unclear , research direct determine risk-benefit ratio , particularly high risk develop adverse drug reaction . In critically ill patient , corticosteroid treatment risk factor infection , hyperglucemia critical-illness neuromuscular abnormality , condition associate increased morbidity mortality . The effect treatment systemic corticosteroid COPD patient acute exacerbation require mechanical ventilation evaluate investigated unknown corticosteroid could reduce duration mechanical ventilation length intensive care unit ( ICU ) stay , contrary , development adverse event could lead long time mechanical ventilation ICU stay . PRIMARY OBJECTIVES : To evaluate effect corticosteroid duration mechanical ventilation , length ICU stay , need tracheal intubation patient treat non-invasive mechanical ventilation . To evaluate frequency adverse event : secondary infection , pneumonia , arterial hypertension , hyperglucemia , gastrointestinal bleeding , critical-illness neuromuscular abnormality . DESING : Multicenter , prospective , randomize , double blind , placebo-controlled clinical trial.The treatment group receive intravenous methylprednisolone 10 day control group receive isotonic saline solution .</brief_summary>
	<brief_title>Evaluation Of The Efficacy Of Corticosteroids In Patients With An Acute Exacerbation Of Chronic Obstructive Pulmonary Disease Receiving Ventilator Support</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Adult patient ( age &gt; 18 year ) admit participate ICUs : 1 . Primary diagnosis COPD exacerbation define presence two follow clinical feature : worsen dyspnea , increase sputum purulence , increase sputum volume 2. respiratory failure [ pH &lt; 7,35 PaCO2 &gt; 45 mm Hg respiratory rate 23 breath per minute ] require mechanical ventilation , invasive noninvasive mechanical ventilation . 1 . Primary diagnosis asthma exacerbation . 2 . History asthma atopy . 3 . Use systemic corticosteroid within precede month . 4 . Use systemic corticosteroid treatment COPD exacerbation time ICU admission 24 hour . 5 . Clinical radiological evidence pneumonia . 6 . Uncontrolled leftventricular failure ( patient evidence severe heart failure require inotropes vasoactive drug ) . 7 . Uncontrolled hypertension arterial ( systolic pressure &gt; 180 mm Hg diastolic pressure &gt; 90 mm Hg despite antihypertensive therapy ) . 8 . Uncontrolled diabetes mellitus . 9 . Presence neuromuscular disease . 10 . History allergy adverse reaction corticosteroid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2005</verification_date>
	<keyword>acute exacerbation COPD</keyword>
</DOC>